JPRN-UMIN000017625已完成未知
Efficacy and safety of sodium-glucose cotransporter-2 inhibitor in patients with type 2 diabetes - ESSENTIAL STUDY
Department of Cardiology, Fukuoka University Hospital.0 个研究点目标入组 50 人开始时间: 2015年5月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Severe ketosis and diabetic coma 2.Type 1 diabetes mellitus 3.Severe liver dysfunction 4.Severe renal dysfunction 5.Pregnancy or lactation in women 6.Patients with a history of allergy to any component of the study medications 7.Patients corresponding to the contraindication of study medications 8.Ineligible patients according to the judgment by physician
研究者
相似试验
招募中
不适用
Efficacy and safety of sodium-glucose co-transporter (SGLT2) inhibitor in diabetic patients with chronic liver diseaseDiabetic patients with chronic liver diseaseJPRN-UMIN000035015Kitasato University School of Medicine100
招募中
不适用
Efficacy and safety of sodium-glucose co-transporter (SGLT2) inhibitor in diabetic patients post renal transplantatioDiabetic patients after kidney transplantJPRN-UMIN000033628Tokyo Women's Medical University School of Medicine15
已完成
不适用
Effecy and Safety of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors on Atrial Fibrillatioatrial fibrillationJPRN-UMIN000024326Hyogo collage of medicine80
尚未招募
不适用
The efficacy of sodium-dependent glucose co-transporter 2(SGLT2) inhibitors for pericardial fat in the type 2 diabetes patientsType 2 diabetes patients with pericardial fat is more than 125 mlJPRN-UMIN000020200ational Hospital Organization Takasaki General Medical Center30
招募中
不适用
Pleiotropic Effects of Sodium glucose co-transporter 2 inhibitor on sympathetic nerve activity and organ network in patients with Type 2 diabetesType2 diabetes patients with multiple atherosclerosis risk factorsType2 diabetesD003924JPRN-jRCTs041200035TAKAMURA Toshinari40